✦ LIBER ✦

A Low Molecular Weight Folate Receptor Targeted Contrast Agent for Magnetic Resonance Tumor Imaging

✍ Scribed by Tammy L. Kalber; Nazila Kamaly; Po-Wah So; John A. Pugh; Josephine Bunch; Cameron W. McLeod; Michael R. Jorgensen; Andrew D. Miller; Jimmy D. Bell

Book ID: 106571621
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 541 KB
Volume: 13
Category: Article
ISSN: 1536-1632
DOI: 10.1007/s11307-010-0400-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gadolinium-Conjugated Dendrimer Nanoclus

Gadolinium-Conjugated Dendrimer Nanoclusters as a Tumor-Targeted T1 Magnetic Resonance Imaging Contrast Agent

✍ Zhiliang Cheng; Daniel L. J. Thorek; Andrew Tsourkas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

Gadolinium-Conjugated Dendrimer Nanoclus

Gadolinium-Conjugated Dendrimer Nanoclusters as a Tumor-Targeted T1 Magnetic Resonance Imaging Contrast Agent

✍ Zhiliang Cheng; Daniel L. J. Thorek; Andrew Tsourkas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

Pharmacokinetics of contrast agents targ

Pharmacokinetics of contrast agents targeted to the tumor vasculature in molecular magnetic resonance imaging

✍ Marlies Oostendorp; Kim Douma; Tilman M. Hackeng; Marc A. M. J. van Zandvoort; M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

MRI contrast agent for molecular imaging

MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles

✍ Samira Rasaneh; Hossein Rajabi; Mohammad Hossein Babaei; Shahram Akhlaghpoor 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 427 KB

A targeted contrast agent for magnetic r

A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution

✍ L.O. Johansson; A. Bjørnerud; H.K Ahlström; D.L. Ladd; D.K. Fujii 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

## Abstract A preparation of ultra‐small superparamagnetic iron oxide (USPIO) particles coupled to an RGD peptide (RGD‐USPIO) was investigated as an MR contrast agent, targeted to activated platelets, in both ex vivo and in vivo thrombus models. Thrombus visualization ex vivo was compared using RGD

Will magnetic resonance imaging (MRI)-ba

Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic?

✍ Kristine Glunde; Zaver M. Bhujwalla 📂 Article 📅 2007 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 412 KB